FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Incredible Video: Heroic Dad Fights Off Gang of Carjackers While Protecting Daughter, Shoots 1 Dead

Knicks Tricked Employees with Fake Championship Ring-Fitting Message, Forced Clickers Into Cybersecurity Courses

Tyler Robinson hearing ends without trial date set, prompting fiery plea from Erika Kirk’s lawyer

Seven Christians Killed, Dozens More Wounded in ‘Heinous’ Attack on Church in Jordan

GOP Congressman Set to Initiate Expulsion Process for ‘Ilhan Omar’ Based on DOJ Findings

Ilhan Omar doubles down on ‘real name’ when confronted at Mall of Somalia

Ilhan Omar calls Trump ‘creep’ as president revives ‘fake name,’ marriage allegations

Meghan Markle’s Statement Triggers Internal Police Investigation Amid ‘Disturbing Allegations’ Against Her Father

Watch: Kamala Harris Turns Back the Clock to 2024, Confuses Crowd with Jumbled Motivational Quote That She Has to Repeat

‘Can’t trust Amy Acton’: Viral ad distracts from what’s really at stake in critical race, GOP strategist says

Federal judge kicked off ‘botch job’ anti-DEI case after stunning appeals court rebuke

Trump says judge is ‘desecrating’ Charlie Kirk’s memory amid fight over assassination trial date

Treasury traces SPLC to debanking of Christians after group dismissed it as conspiracy

Mass shooting at Jordanian church kills at least seven and wounds dozens

Polish Left pushing abortion liberalization through parliament despite looming presidential veto

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”